
Przewidywanie ciężkości COVID-19
Julian
- 0
Przewidywanie ciężkości COVID-19 za pomocą swoistego przeciwciała nukleokapsydowego i wskaźnika czynnika ryzyka choroby
Efficient strategies for predicting COVID-19 illness trajectories are urgently wanted. Right here, enzyme-linked immunosorbent assay (ELISA) and coronavirus antigen microarray (COVAM) evaluation mapped antibody epitopes within the plasma of COVID-19 sufferers (n = 86) experiencing a variety of illness states. The experiments recognized antibodies to a 21-residue epitope from nucleocapsid (termed Ep9) related to extreme illness, together with admission to the intensive care unit (ICU), requirement for ventilators, or demise.
Importantly, anti-Ep9 antibodies will be detected inside 6 days post-symptom onset and generally inside 1 day. Moreover, anti-Ep9 antibodies correlate with varied comorbidities and hallmarks of immune hyperactivity. We introduce a simple-to-calculate, illness threat issue rating to quantitate every affected person’s comorbidities and age. For sufferers with anti-Ep9 antibodies, scores above 3.Zero predict extra extreme illness outcomes with a 13.42 chance ratio (96.7% specificity).
The outcomes lay the groundwork for a brand new sort of COVID-19 prognostic to permit early identification and triage of high-risk sufferers. Such info might information more practical therapeutic intervention.IMPORTANCE The COVID-19 pandemic has resulted in over two million deaths worldwide. Regardless of efforts to struggle the virus, the illness continues to overwhelm hospitals with severely unwell sufferers.
Prognosis of COVID-19 is instantly completed by a mess of dependable testing platforms; nonetheless, prognostic prediction stays elusive. To this finish, we recognized a brief epitope from the SARS-CoV-2 nucleocapsid protein and likewise a illness threat issue rating primarily based upon comorbidities and age. The presence of antibodies particularly binding to this epitope plus a rating cutoff can predict extreme COVID-19 outcomes with 96.7% specificity.

Anti-IGF-IIR antibody |
|||
STJ96634 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to IGF-IIR. |
Anti-IGF-IR antibody |
|||
STJ93647 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: IGF-IR is a protein encoded by the IGF1R gene which is approximately 154,7 kDa. IGF-IR is localised to the cell membrane. It is involved in apoptotic pathways, the GPCR pathway and ERK signalling. It is a receptor tyrosine kinase which mediates actions of insulin-like growth factor 1. The activated protein is involved in cell growth and survival control and is also crucial for tumour transformation and survival of malignant cells. It is formed from two subunits, each of which is comprised of an extracellular alpha-subunit and a transmembrane beta-subunit with intracellular tyrosine kinase activity. IGF-IR is expressed in the nervous system, skin, pancreas, lung and muscle. Mutations in the IGF1R gene may result in insulin-like growth factor 1 resistance. STJ93647 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This polyclonal antibody detects endogenous levels of IGF-IR protein. |
Anti-IGF-IR antibody |
|||
STJ93648 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to IGF-IR. |
Anti-IGF-I antibody |
|||
STJ93653 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to IGF-I. |
Anti-IGF-IIR antibody |
|||
STJ93654 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to IGF-IIR. |
Anti-IGF-IIR antibody |
|||
STJ93655 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to IGF-IIR. |
Anti-IGF-IR antibody |
|||
STJ93656 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to IGF-IR. |
Anti-IGF-IR antibody |
|||
STJ93657 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to IGF-IR. |
Anti-IGF-IR antibody |
|||
STJ98158 | St John's Laboratory | 100 µl | EUR 280.8 |
Description: Mouse monoclonal to IGF-IR. |
Anti-IGF-IR antibody |
|||
STJ98159 | St John's Laboratory | 100 µl | EUR 280.8 |
Description: Mouse monoclonal to IGF-IR. |
Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST μ-form |
|||
GST-ANTI-2 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 336 |
Human Salivary IGF(salivary IGF) ELISA Kit |
|||
QY-E05383 | Qayee Biotechnology | 96T | EUR 433.2 |
IGF-1, Human |
|||
HY-P7018 | MedChemExpress | 10ug | EUR 129.6 |
IGF-2, Human |
|||
HY-P7019 | MedChemExpress | 100ug | EUR 432 |
IGF-BP3, Human |
|||
HY-P7020 | MedChemExpress | 10ug | EUR 280.8 |
IGF-BP5, Human |
|||
HY-P7021 | MedChemExpress | 50ug | EUR 721.2 |
IGF-1, human |
|||
RC216-12 | Bio Basic | 1mg | EUR 451.5 |
IGF-BP3, human |
|||
RC216-12B3 | Bio Basic | 5ug | EUR 125.26 |
Anti-Rat IGF-1 Antibody |
|||
5121-100 | Biovision | EUR 379.2 |
Anti-Rat IGF-1 Antibody |
|||
5121-30T | Biovision | EUR 175.2 |
anti-IGF-1R (Ab-1280) |
|||
LF-PA20229 | Abfrontier | 100 ul | EUR 400.8 |
Description: Rabbit polyclonal to IGF-1R |
anti-IGF-1R (Ab-1346) |
|||
LF-PA20230 | Abfrontier | 100 ul | EUR 400.8 |
Description: Rabbit polyclonal to IGF-1R |
anti-IGF-1R (Ab-1161) |
|||
LF-PA20231 | Abfrontier | 100 ul | EUR 400.8 |
Description: Rabbit polyclonal to IGF-1R |
anti-IGF-1R (Phospho-Tyr1161) |
|||
LF-PA20233 | Abfrontier | 100 ul | EUR 424.8 |
Description: Rabbit polyclonal to IGF-1R (Phospho-Tyr1161) |
Anti-IGF-1R (Teprotumumab), Human IgG1 Antibody |
|||
A2160-100 | Biovision | 100 µg | EUR 612 |
IGF-II |
|||
PR15045CF | Neuromics | 50 ug | EUR 333.6 |
Human [Ala31] IGF-I |
|||
AIU020 | GroPep | 20 µg | EUR 303.6 |
Human [Ala31] IGF-I |
|||
AIU100 | GroPep | 100 µg | EUR 415.2 |
IGF-BP2, human recombinant |
|||
7165-10 | Biovision | EUR 301.2 |
IGF-BP2, human recombinant |
|||
7165-50 | Biovision | EUR 1123.2 |
IGF-BP7, human recombinant |
|||
7167-10 | Biovision | EUR 248.4 |
IGF-BP7, human recombinant |
|||
7167-50 | Biovision | EUR 810 |
IGF-BP6, human recombinant |
|||
7350-20 | Biovision | EUR 444 |
IGF-BP1, human recombinant |
|||
4717-100 | Biovision | EUR 744 |
IGF-BP1, human recombinant |
|||
4717-1000 | Biovision | EUR 3778.8 |
IGF-BP1, human recombinant |
|||
4717-25 | Biovision | EUR 307.2 |
IGF-BP3, human recombinant |
|||
4720-100 | Biovision | EUR 744 |
IGF-BP3, human recombinant |
|||
4720-1000 | Biovision | EUR 3778.8 |
IGF-BP3, human recombinant |
|||
4720-25 | Biovision | EUR 307.2 |
IGF-BP5, human recombinant |
|||
4723-100 | Biovision | EUR 744 |
IGF-BP5, human recombinant |
|||
4723-1000 | Biovision | EUR 3778.8 |
IGF-BP5, human recombinant |
|||
4723-25 | Biovision | EUR 307.2 |
IGF-I, human recombinant |
|||
4119-100 | Biovision | EUR 210 |
IGF-I, human recombinant |
|||
4119-1000 | Biovision | EUR 411.6 |
IGF-I, human recombinant |
|||
4119-10MG | Biovision | EUR 1834.8 |
IGF-I, human recombinant |
|||
4119-1G | Biovision | EUR 49388.4 |
IGF-I, human recombinant |
|||
4119-20MG | Biovision | EUR 2793.6 |
IGF-I, human recombinant |
|||
4119-5000 | Biovision | EUR 1149.6 |
IGF-I, human recombinant |
|||
4119-50MG | Biovision | EUR 5064 |
IGF-II, human recombinant |
|||
4122-10 | Biovision | EUR 164.4 |
IGF-II, human recombinant |
|||
4122-1000 | Biovision | EUR 1886.4 |
IGF-II, human recombinant |
|||
4122-50 | Biovision | EUR 307.2 |
Human [Leu60] IGF-I |
|||
ABU020 | GroPep | 20 µg | EUR 303.6 |
Human [Leu60] IGF-I |
|||
ABU100 | GroPep | 100 µg | EUR 415.2 |
Human IGF-I Protein |
|||
abx060791-100ug | Abbexa | 100 ug | EUR 560.4 |
Biotinyl Human IGF-I |
|||
AQU010 | GroPep | 10 µg | EUR 303.6 |
Biotinyl Human IGF-I |
|||
AQU050 | GroPep | 50 µg | EUR 415.2 |
Biotinyl Human IGF-I |
|||
AQU100 | GroPep | 100 µg | EUR 637.2 |
Biotinyl Human IGF-I |
|||
AQU500 | GroPep | 500 µg | EUR 1305.6 |
IGF-1, human recombinant |
|||
P1016-.02 | ApexBio | 20 µg | EUR 309.6 |
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue |
IGF-1, human recombinant |
|||
P1016-.1 | ApexBio | 100 µg | EUR 915.6 |
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue |
IGF-II, human recombinant |
|||
P1017-.01 | ApexBio | 10 µg | EUR 193.2 |
Description: Insulin-like Growth Factor-II (IGF-II) is a polypeptide endocrine hormone structurally similar to insulin and belongs to insulin-like growth factor family. |
IGF-II, human recombinant |
|||
P1017-.05 | ApexBio | 50 µg | EUR 375.6 |
Description: Insulin-like Growth Factor-II (IGF-II) is a polypeptide endocrine hormone structurally similar to insulin and belongs to insulin-like growth factor family. |
IGF-II, human recombinant |
|||
P1017-1 | ApexBio | 1 mg | EUR 2397.6 |
Description: Insulin-like Growth Factor-II (IGF-II) is a polypeptide endocrine hormone structurally similar to insulin and belongs to insulin-like growth factor family. |
rec IGF-I (human) |
|||
H-5555.0050 | Bachem | 50.0µg | EUR 290.4 |
Description: CAS# [67763-96-6] |
rec IGF-I (human) |
|||
H-5555.0100 | Bachem | 100.0µg | EUR 457.2 |
Description: CAS# [67763-96-6] |
rec IGF-I (human) |
|||
H-5555.0500 | Bachem | 0.5mg | EUR 1720.8 |
Description: CAS# [67763-96-6] |
Human [Arg6] IGF-II |
|||
GU020 | GroPep | 20 µg | EUR 303.6 |
Human IGF-1 LR3 |
|||
SP-89927-100 | Alpha Diagnostics | 100 ug | EUR 270 |
Human [Leu24] IGF-I |
|||
ZU020 | GroPep | 20 µg | EUR 303.6 |
Human [Leu24] IGF-I |
|||
ZU100 | GroPep | 100 µg | EUR 415.2 |
Human [Leu27]IGF-II |
|||
TU100 | GroPep | 100 µg | EUR 415.2 |
Anti-IGF-1R (Ab-1161) Antibody |
|||
A00070-1 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal IGF-1R (Ab-1161) Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat. |
Polyclonal Anti-Rat IGF-1 Antibody |
|||
APR00269G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Anti-Rat IGF-1 . This antibody is tested and proven to work in the following applications: |
anti-IGF-1R (Ab-1165/1166) |
|||
LF-PA20232 | Abfrontier | 100 ul | EUR 400.8 |
Description: Rabbit polyclonal to IGF-1R |
anti-IGF-1R (Phospho-Tyr1165/Tyr1166) |
|||
LF-PA20234 | Abfrontier | 100 ul | EUR 424.8 |
Description: Rabbit polyclonal to IGF-1R (Phospho-Tyr1165/Tyr1166) |
Anti-Phospho-IGF-IR (Y1161) antibody |
|||
STJ90298 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to Phospho-IGF-IR (Y1161). |
Anti-Phospho-IGF-IIR (S2409) antibody |
|||
STJ90923 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to Phospho-IGF-IIR (S2409). |
Anti-Phospho-IGF-IR (Y1161) antibody |
|||
STJ91026 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to Phospho-IGF-IR (Y1161). |
Anti-Phospho-IGF-IR (Y1346) antibody |
|||
STJ91187 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to Phospho-IGF-IR (Y1346). |
IGF-2/ Rat IGF- 2 ELISA Kit |
|||
ELA-E0051r | Lifescience Market | 96 Tests | EUR 1063.2 |
Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-100ug |
|||
QP8601-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-10ug |
|||
QP8601-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-1mg |
|||
QP8601-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-200ug |
|||
QP8601-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-500ug |
|||
QP8601-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human IGF-2/ IGF-II Protein, GST, E.coli-50ug |
|||
QP8601-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-100ug |
|||
QP5264-100ug | EnQuireBio | 100ug | EUR 435.6 |
Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-10ug |
|||
QP5264-10ug | EnQuireBio | 10ug | EUR 163.2 |
Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-1mg |
|||
QP5264-1mg | EnQuireBio | 1mg | EUR 1513.2 |
Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-500ug |
|||
QP5264-500ug | EnQuireBio | 500ug | EUR 914.4 |
Recombinant Human IGF-2/ IGF-II Protein, Untagged, E.coli-50ug |
|||
QP5264-50ug | EnQuireBio | 50ug | EUR 284.4 |
Mouse Anti-Human IGF-1R monoclonal antibody, clone JID716 |
|||
CABT-L2807-100uL500uL | Creative Diagnostics | 100 uL, 500 uL | EUR 602.4 |
Anti-IGF1/Igf I Rabbit Monoclonal Antibody |
|||
M00148 | BosterBio | 100ug/vial | EUR 476.4 |
Description: Rabbit Monoclonal IGF1/Igf I Antibody. Validated in WB and tested in Human. |
Anti-IGF2/Igf Ii Rabbit Monoclonal Antibody |
|||
M00335 | BosterBio | 100ug/vial | EUR 476.4 |
Description: Rabbit Monoclonal IGF2/Igf Ii Antibody. Validated in IF, WB and tested in Human. |
Anti-Phospho-IGF-IR (Y1165/Y1166) antibody |
|||
STJ90299 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to Phospho-IGF-IR (Y1165/Y1166). |
Human IGF-I (Receptor Grade) |
|||
CM001 | GroPep | 1 mg | EUR 1082.4 |
Human IGF-I (Receptor Grade) |
|||
CM005 | GroPep | 5 mg | EUR 195.6 |
Human IGF-I (Receptor Grade) |
|||
CU020 | GroPep | 20 µg | EUR 303.6 |
Human IGF-I (Receptor Grade) |
|||
CU100 | GroPep | 100 µg | EUR 415.2 |
Human [Leu24] [Ala31] IGF-I |
|||
ADU020 | GroPep | 20 µg | EUR 303.6 |
Human [Ala31] [Leu60] IGF-I |
|||
ALU020 | GroPep | 20 µg | EUR 303.6 |
Human [Ala31] [Leu60] IGF-I |
|||
ALU100 | GroPep | 100 µg | EUR 415.2 |
Human IGF-II (Receptor Grade) |
|||
FM001 | GroPep | 1 mg | EUR 193.2 |
Human IGF-2 ELISA Kit |
|||
EHI0307 | Abclonal | 96Tests | EUR 625.2 |
R³ IGF-1, human recombinant |
|||
4216-100 | Biovision | EUR 196.8 |
R³ IGF-1, human recombinant |
|||
4216-1G | Biovision | EUR 48018 |
R³ IGF-1, human recombinant |
|||
4216-1MG | Biovision | EUR 385.2 |
Związek między poziomami alarmin w surowicy a wskaźnikami specyficznymi dla choroby u pacjentów z zapaleniem naczyń związanym z cytoplazmatycznymi przeciwciałami przeciw neutrofilom
Background/purpose: We evaluated the connection between serum alarmin ranges and disease-specific indices in sufferers with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Sufferers and strategies: Sera and information from 79 sufferers had been utilized. For AAV-specific indices, Birmingham vasculitis exercise rating (BVAS), five-factor rating (FFS), and vasculitis harm index (VDI) had been collected and serum ranges of 4 alarmins (hepatoma-derived progress issue, excessive mobility group field protein 1, S100A9, and S100A12) had been measured utilizing enzyme-linked immunosorbent assay. Associations between alarmin ranges, AAV-specific indices, and inflammatory laboratory markers had been assessed.
Outcomes: S100A9 ranges had been considerably correlated with C-reactive protein ranges (r=0.316, p=0.005) and S100A12 ranges correlated with VDI (r=0.232, p=0.040), which was constant in a subgroup of sufferers with myeloperoxidase (perinuclear)-ANCA positivity. No different associations had been discovered between alarmin ranges and BVAS, FFS, and VDI.
Conclusion: The serum S100A12 degree was related to organ harm in AAV, particularly in myeloperoxidase (perinuclear)-ANCA-positive sufferers.
Zapalenie skórno-mięśniowe z dodatnim przeciwciałem anty-MDA5 z szybko postępującą śródmiąższową chorobą płuc: opis dwóch przypadków
Melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (DM) shows distinctive cutaneous and pathologic options. We describe two circumstances of myositis-associated quickly progressive interstitial lung illness (RP-ILD).
The sufferers had been two girls from Kerala, India. Each sufferers had anti-MDA5 antibody-positive myositis. Each sufferers offered with RP-ILD with none scientific options of myositis and succumbed to their sickness regardless of aggressive medical therapy. Anti-MDA5-antibody-positive DM is characterised by amyopathic illness with quickly progressive and deadly ILD.
Charakterystyka przeciwciał monoklonalnych przeciw tężcowi jako pierwszy krok w kierunku opracowania testu immunologicznego na siłę szczepionki in vitro
Batch launch testing for human and veterinary tetanus vaccines nonetheless depends closely on strategies that contain animals, notably for efficiency testing. The amount and high quality of tetanus antigen current in these merchandise is of utmost significance for product security and scientific impact. Immunochemical strategies that measure consistency of antigen content material and high quality, doubtlessly as an indicator of efficiency, may very well be a better option and negate the necessity for an in vivo efficiency check. These immunochemical strategies require at the least one nicely characterised monoclonal antibody (mAb) that’s particular for the goal antigen. On this paper we report the outcomes of the excellent characterisation of a panel of mAbs towards tetanus with a view to pick antibodies that can be utilized for improvement of an in vitro efficiency immunoassay.
We’ve assessed binding of the antibodies to native antigen (toxin), detoxified antigen (toxoid), adsorbed antigen and heat-altered antigen. Antibody perform was decided utilizing an in-house cell-based neutralisation assay to assist prior in vivo efficiency information that was obtainable for some, however not all, of the antibodies. As well as, antibody affinity was measured, and epitope competitors evaluation was carried out to establish pairs of antibodies that may very well be deployed in a sandwich immunoassay format. Not all characterisation assessments offered proof of “superiority” of 1 mAb over one other, however collectively the outcomes from all characterisation research allowed for choice of an antibody pair to be taken ahead to assay improvement.
Opis przypadku: autoimmunologiczne zapalenie mózgu związane z przeciwciałami dekarboksylazy kwasu przeciwglutaminowego: seria przypadków pediatrycznych
Background: Antibodies towards glutamic acid decarboxylase (GAD) are related to varied neurologic circumstances described in sufferers, together with stiff particular person syndrome, cerebellar ataxia, refractory epilepsy, and limbic and extralimbic encephalitis. There have been some case stories and investigations relating to anti-GAD65 antibody-associated encephalitis in grownup populations, however pediatric circumstances are uncommon. We retrospectively analyzed the scientific information of three anti-GAD65 antibody-positive sufferers to discover the range and scientific options of anti-GAD65 antibody-associated pediatric autoimmune encephalitis.
Strategies: The scientific information of a sequence of three sufferers optimistic for anti-GAD65 antibody had been retrospectively analyzed. GAD65 antibodies had been decided in serum and CSF utilizing a cell-based assay.
Outcomes: All three sufferers had been feminine, and the onset ages had been four years and 9 months, 6 years, and 16 years previous. Their scientific phenotypes included autoimmune limbic encephalitis, extralimbic encephalitis, and encephalitis combining limbic and extralimbic encephalitis. The scientific signs included seizures, reminiscence deficits, drowsiness, dysautonomia, and headache. All sufferers had irregular carinal MRI and EEG. All sufferers obtained immunotherapy and had transiently good responsiveness, however one affected person then skilled relapse. In follow-up, one affected person with extralimbic encephalitis recovered utterly, whereas two sufferers with limbic involvement had poor outcomes with refractory focal epilepsy.
Conclusion: Along with limbic encephalitis, extralimbic encephalitis can also be an necessary phenotype in sufferers who’re optimistic for anti-GAD65 antibodies. Early analysis and immunotherapy can enhance the signs. Nevertheless, sufferers with limbic encephalitis typically have refractory epilepsy within the continual section and have a poor long-term final result.
Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 336 |
CXCL7 ELISA KIT|Human |
|||
EF001450 | Lifescience Market | 96 Tests | EUR 826.8 |
Human CXCL7 ELISA Kit |
|||
LF-EK50893 | Abfrontier | 1×96T | EUR 777.6 |
NAP-2/CXCL7, Human |
|||
HY-P7268 | MedChemExpress | 50ug | EUR 639.6 |
NAP-2/CXCL7, Rat |
|||
HY-P7269 | MedChemExpress | 50ug | EUR 639.6 |
NAP-2, CXCL7, human |
|||
RC312-18 | Bio Basic | 2ug | EUR 125.26 |
NAP-2, CXCL7, rat |
|||
RC352-18 | Bio Basic | 2ug | EUR 125.26 |
NAP-2 Antibody / CXCL7 |
|||
R31872 | NSJ Bioreagents | 100 ug | EUR 419 |
Mouse beta Thromboglobulin (CXCL7/bTG) CLIA Kit |
|||
20-abx491403 | Abbexa |
|
|
Human CXCL7 Antibody (Biotin Conjugate) |
|||
32852-05121 | AssayPro | 150 ug | EUR 442.8 |
Human CXCL7 PicoKine ELISA Kit |
|||
EK0729 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human CXCL7 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human CXCL7 AssayMax ELISA Kit |
|||
EC2270-1 | AssayPro | 96 Well Plate | EUR 572.4 |
ELISA kit for Human CXCL7 |
|||
EK5304 | SAB | 96 tests | EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human CXCL7 in samples from serum, plasma, tissue homogenates and other biological fluids. |
NAP-2 Antibody / CXCL7 / PPBP |
|||
RQ4113 | NSJ Bioreagents | 100 ug | EUR 419 |
Human CXCL7 AssayLite Antibody (FITC Conjugate) |
|||
32852-05141 | AssayPro | 150 ug | EUR 513.6 |
Human CXCL7 AssayLite Antibody (RPE Conjugate) |
|||
32852-05151 | AssayPro | 150 ug | EUR 513.6 |
Human CXCL7 AssayLite Antibody (APC Conjugate) |
|||
32852-05161 | AssayPro | 150 ug | EUR 513.6 |
Human CXCL7 AssayLite Antibody (PerCP Conjugate) |
|||
32852-05171 | AssayPro | 150 ug | EUR 565.2 |
Neutrophil Activating Protein-2 (CXCL7) Antibody |
|||
20-abx137035 | Abbexa |
|
|
Neutrophil Activating Protein-2 (CXCL7) Protein |
|||
20-abx261559 | Abbexa |
|
|
Neutrophil Activating Protein-2 (CXCL7) Protein |
|||
20-abx261561 | Abbexa |
|
|
Rat PPBP/CXCL7 PicoKine ELISA Kit |
|||
EK0731 | BosterBio | 96 wells | EUR 510 |
Description: For Quantitative Detection of rat CXCL7 in cell culture supernates, serum and plasma (heparin, EDTA). |
NAP-2/CXCL7 (CHO-expressed), Human |
|||
HY-P7267 | MedChemExpress | 50ug | EUR 596.4 |
ThymusChemokine‑1/CXCL7 (CHO-expressed), Rat |
|||
HY-P7301 | MedChemExpress | 10ug | EUR 349.2 |
Nori Equine CXCL7/NAP2 ELISA Kit |
|||
GR106909 | Genorise Scientific | 96-well | EUR 553.2 |
Nori® Hamster CXCL7 ELISA Kit |
|||
GR172274 | Genorise Scientific | 96-well | EUR 553.2 |
Nori® Canine CXCL7 ELISA Kit |
|||
GR115398 | Genorise Scientific | 96-well | EUR 553.2 |
Recombinant Human CXCL7/NAP-2 Protein |
|||
RP00829 | Abclonal | 10 μg | EUR 265.2 |
ELISA kit for Mouse ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) |
|||
E-EL-M1269 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
Description: A sandwich ELISA kit for quantitative measurement of Mouse ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) in samples from Serum, Plasma, Cell supernatant |
Recombinant Human Neutrophil Activating Protein-2 (CXCL7) |
|||
7-02059 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Neutrophil Activating Protein-2 (CXCL7) |
|||
7-02060 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Neutrophil Activating Protein-2 (CXCL7) |
|||
7-02061 | CHI Scientific | 1mg | Ask for price |
Recombinant Rat Neutrophil Activating Protein-2 (CXCL7) |
|||
7-02065 | CHI Scientific | 2µg | Ask for price |
Recombinant Rat Neutrophil Activating Protein-2 (CXCL7) |
|||
7-02066 | CHI Scientific | 10µg | Ask for price |
Recombinant Rat Neutrophil Activating Protein-2 (CXCL7) |
|||
7-02067 | CHI Scientific | 1mg | Ask for price |
Human CXCL7(Platelet basic protein) ELISA Kit |
|||
EH0007 | FN Test | 96T | EUR 681.12 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 9.375pg/ml |
Nori® Human CXCL7-NAP2 ELISA Kit |
|||
GR106282 | Genorise Scientific | 96-well | EUR 553.2 |
Human Platelet Basic Protein / CXCL7 (PPBP) ELISA Kit |
|||
abx252283-96tests | Abbexa | 96 tests | EUR 801.6 |
Neutrophil Activating Protein-2 (CXCL7), 95 a.a. Protein |
|||
20-abx260678 | Abbexa |
|
|
Pig Platelet Basic Protein / CXCL7 (PPBP) ELISA Kit |
|||
abx511493-96tests | Abbexa | 96 tests | EUR 1093.2 |
Rat Platelet Basic Protein / CXCL7 (PPBP) ELISA Kit |
|||
abx255841-96tests | Abbexa | 96 tests | EUR 801.6 |
Recombinant (E.Coli) Human Neutrophil Activating Protein-2 (CXCL7) |
|||
RP-1008 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 95 a.a. |
|||
7-02062 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 95 a.a. |
|||
7-02063 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 95 a.a. |
|||
7-02064 | CHI Scientific | 1mg | Ask for price |
Human Thromboglobulin, Beta (bTG/PBP/CXCL7/NAP2) CLIA Kit |
|||
abx197774-96tests | Abbexa | 96 tests | EUR 990 |
ELISA kit for Human ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) |
|||
E-EL-H1007 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
Description: A sandwich ELISA kit for quantitative measurement of Human ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) in samples from Plasma |
ELISA kit for Rat ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) |
|||
E-EL-R1087 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
Description: A sandwich ELISA kit for quantitative measurement of Rat ?TG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) in samples from Serum, Plasma, Cell supernatant |
Human CXCL7 EZ-Set™ ELISA Kit (DIY Antibody Pairs) |
|||
EZ0729 | BosterBio | 5 plates/kit | EUR 321.6 |
Description: For the development of sandwich ELISA kit to measure human CXCL7 in cell culture supernates, cell lysates, tissue homogenates, serum and plasma (heparin, EDTA). |
NAP-2 Neutrophil Activating Protein-2 Human Recombinant Protein (CXCL7) |
|||
PROTP02775 | BosterBio | Regular: 10ug | EUR 380.4 |
Description: Neutrophil Activating Protein-2 Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 70 amino acids and having a molecular mass of 7609 Dalton. ;The NAP-2 is purified by proprietary chromatographic techniques. |
NAP-2 Neutrophil Activating Protein-2 Rat Recombinant Protein (CXCL7) |
|||
PROTQ99ME0 | BosterBio | Regular: 10ug | EUR 380.4 |
Description: NAP-2 Rat Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 62 amino acids and having a molecular mass of 6.8kDa.;The NAP 2 is purified by proprietary chromatographic techniques. |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-100ug |
|||
QP10212-ec-100ug | EnQuireBio | 100ug | EUR 1185.6 |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-10ug |
|||
QP10212-ec-10ug | EnQuireBio | 10ug | EUR 348 |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-250ug |
|||
QP10212-ec-250ug | EnQuireBio | 250ug | EUR 2077.2 |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-2ug |
|||
QP10212-ec-2ug | EnQuireBio | 2ug | EUR 184.8 |
Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-100ug |
|||
QP10285-ec-100ug | EnQuireBio | 100ug | EUR 1413.6 |
Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-10ug |
|||
QP10285-ec-10ug | EnQuireBio | 10ug | EUR 348 |
Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-250ug |
|||
QP10285-ec-250ug | EnQuireBio | 250ug | EUR 2480.4 |
Recombinant Rat NAP-2/ PPBP/ CXCL7 Protein, Untagged, E.coli-2ug |
|||
QP10285-ec-2ug | EnQuireBio | 2ug | EUR 184.8 |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-100ug |
|||
QP8641-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-10ug |
|||
QP8641-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-1mg |
|||
QP8641-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-200ug |
|||
QP8641-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-500ug |
|||
QP8641-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human NAP-2/ PPBP/ CXCL7 Protein, GST, E.coli-50ug |
|||
QP8641-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2 |
|||
C056-10ug | Novoprotein | 10ug | EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2 |
|||
C056-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2 |
|||
C056-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human C-X-C Motif Chemokine 7/CXCL7/NAP-2 |
|||
C056-50ug | Novoprotein | 50ug | EUR 595.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
NAP-2-95 Neutrophil Activating Protein-2 (CXCL7) Human Recombinant Protein, 95 a.a. |
|||
PROTP02775-1 | BosterBio | Regular: 10ug | EUR 380.4 |
Description: NAP 2 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 95 amino acids (35-128) and having a molecular mass of 10.3 kDa.;The NAP 2 is purified by proprietary chromatographic techniques. |
Mouse anti IgA1 |
|||
10-I06A | Fitzgerald | 1 mg | EUR 369.6 |
Description: Mouse anti IgA1 antibody |
UltraTek Anti-Mouse |
|||
ABJ008 | ScyTek Laboratories | 8 ml | EUR 96 |
UltraTek Anti-Mouse |
|||
ABJ015 | ScyTek Laboratories | 15 ml | EUR 117.6 |
UltraTek Anti-Mouse |
|||
ABJ125 | ScyTek Laboratories | 125 ml | EUR 273.6 |
UltraTek Anti-Mouse |
|||
ABJ500 | ScyTek Laboratories | 500 ml | EUR 664.8 |
UltraTek Anti-Mouse |
|||
ABJ999 | ScyTek Laboratories | 1000 ml | EUR 1120.8 |
SensiTek Anti-Mouse |
|||
ABC008 | ScyTek Laboratories | 8 ml | EUR 85.2 |
SensiTek Anti-Mouse |
|||
ABC015 | ScyTek Laboratories | 15 ml | EUR 96 |
SensiTek Anti-Mouse |
|||
ABC125 | ScyTek Laboratories | 125 ml | EUR 211.2 |
SensiTek Anti-Mouse |
|||
ABC500 | ScyTek Laboratories | 500 ml | EUR 504 |
SensiTek Anti-Mouse |
|||
ABC999 | ScyTek Laboratories | 1000 ml | EUR 853.2 |
anti-mouse VLK |
|||
AR03-PA0002 | Abfrontier | 100 ul | EUR 400.8 |
Description: Rabbit polyclonal to VLK |
Mouse Anti-FcεRIα |
|||
MOFCeRIaAP(V100) | ImmunoStep | 100 ug | EUR 60 |
Mouse Anti-FcεRIα |
|||
MOFCeRIaAP(V25) | ImmunoStep | 25 ug | EUR 60 |
Mouse Anti-FcεRIα |
|||
MOFCeRIaB(V100) | ImmunoStep | 100 ug | EUR 60 |
Mouse Anti-FcεRIα |
|||
MOFCeRIaB(V25) | ImmunoStep | 25 ug | EUR 60 |
Mouse Anti-FcεRIα |
|||
MOFCeRIaCFB(V100) | ImmunoStep | 100 ug | EUR 60 |
Mouse Anti-FcεRIα |
|||
MOFCeRIaCFB(V25) | ImmunoStep | 25 ug | EUR 60 |
Mouse Anti-FcεRIα |
|||
MOFCeRIaF(V100) | ImmunoStep | 100 ug | EUR 60 |
Mouse Anti-FcεRIα |
|||
MOFCeRIaF(V25) | ImmunoStep | 25 ug | EUR 60 |